Affini-T Therapeutics to Present AFNT-211 T Cell Product Attributes Targeting KRAS G12V at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting
BOSTON & SEATTLE--(BUSINESS WIRE)--May 25, 2023--
Source: wsiltv.com
Fast, Ad-Free News Updates
Stay updated with breaking news from Presenting Authors. Real-time updates on events, politics, business and more.